Laboratoires SMB SA - Company Review
Laboratoires SMB SA - Company ReviewSummary
Laboratoires SMB SA (S.M.B) is a pharmaceutical company that researches, develops and manufactures pharmaceutical products. The company offers prescription drugs such as central nervous system, antibiotics, cardiology, dermatology, gastro-intestinal, pain management and respiratory, and over-the counter drugs for cough and cold, and vitamin deficiency. It provides formulation products that include dry powder inhaler, lidose, pellets, effervescent tablet and divule. S.M.B offers pellets that are pharmaceutical microgranules manufactured by a granulation-extrusion-spheronisation process. The laboratory comprises variety of products for respiratory tract, cardiovascular systems, pain management, and over the counter drugs. It is specialized in the development, production and packaging of solid dosage forms. S.M.B is headquartered in Brussels, Belgium.
This comprehensive company report of Laboratoires SMB SA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.